Washington, President Trump signed an executive order Thursday that reclassifies marijuana from Schedule I to Schedule III, directing the Justice Department and DEA to implement the change and opening federal avenues for medical research, potential tax adjustments for licensed businesses, and expanded banking access; states retain their own marijuana laws. Officials said the order acknowledges medical use but does not legalize recreational use nationwide. Industry groups, veteran advocates and state regulators responded this week with statements on anticipated impacts and next steps as federal agencies begin review, and congressional oversight reviews continue. Based on 11 articles reviewed and supporting research.
Prepared by Lauren Mitchell and reviewed by editorial team.
Federal rescheduling could benefit medical researchers, licensed cannabis businesses, patients seeking medical access, banks considering cannabis clients, and investors by potentially easing research barriers, reducing tax burdens, and expanding financial services access contingent on DEA and Justice Department implementation.
Opponents of legalization may see policy shifts; some small producers could face pricing pressure as Michigan retail prices have fallen, and individuals relying on state-level restrictions may encounter changing regulatory frameworks while federal illegality for some offenses persists until statutory changes occur.
No left-leaning sources found for this story.
Federal Rescheduling Moves Marijuana to Schedule III
WTNH CBS News PBS.org Pulse24.com http://www.wtol.com 7 News Miami https://www.ksnblocal4.com The Spokesman ReviewTrump set to deliver pot reform dream -- but rescheduling stops...
New York Post Boston Herald FOX 55 Fort Wayne
Comments